Amarantus Bioscience Holdings, Inc. (AMBS: Pink Limited) | MANF Therapeutics Receives Notice of Allowance from US Patent & Trademark Office Covering the Use of MANF or CDNF as a Treatment for Glaucoma, Macular Degeneration and Retinitis Pigmentosa
(0)
(0)